In a systematic review of randomized clinical trials, 6.5% of those using a GLP-1RA discontinued it due to adverse events versus 3.6% of those on placebo (16), but these rates appear to be higher in observational studies where factors associated with discontinuation were an age of 65 years or older and GI adverse events with treatment (21)
Enhance efficiency and drive better outcomes schedule a call today: The GLP-1 Receptor Agonist Market: Segmentation Analysis By product analysis The Ozempic segment held the biggest revenue share of the GLP-1 receptor agonist market in 2024
Staying patient, following your treatment plan, and maintaining healthy lifestyle habits can help you achieve the best possible results over time
The Microdose GLP-1 Rx Program is priced at $99 to start, followed by $199 per month, which includes medication, if prescribed, and Nooms powerful GLP-1 Companion, providing clinical care, coaching, and a personalized healthy habits program
In results published in The New England Journal of Medicine, a once-weekly regimen combining cagrilintide and semaglutide (CagriSema) delivered levels of weight reduction that were previously difficult to achieve with drugs alone
Assess the patients level of consciousness and cognitive function
